menu
ALLOTCBB Top Rated Top Upgraded Most Active Gainers Losers

PROVECTUS BIOPHARM COM USD0.001 (PVCT)
0.03345 -0.00675 (-16.79104%) 10/19/2017 3:59pm
Open: 0.04250 Prev Close: 0.04020
High: 0.04250 Low: 0.03020
Volume: 2592230 Market Cap: 12.39M
Year High: 0.08000 Year Low: 0.01100
Stock Technical Analysis
Overall       
Targets Six months: 0.0526    One year: 0.0614
Supports Support1: 0.0296   Support2: 0.0200
Resistances Resistance1: 0.0450    Resistance2: 0.0526 
Pivot Point 0.0314 
Moving Averages MA(5): 0.0365      MA(20): 0.0300 

MA(100): 0.0310  -1     MA(250): 0.0322 
MACD MACD(12,26): 0.003      Signal(12,26,9): 0.002 
Stochastic Oscillator %K(14,3): 68.095      %D(3): 75.634 
RSI RSI(14): 55.711 
52-Week High: 0.0750  Low: 0.0110  Change(%): -46
Average Volume(K) 3-Month: 32728  10-Days: 1056
Moving Averages analysis
Price and moving averages has closed above its Short term moving average. Short term moving average is above its mid-term; and above long term moving averages. From the relationship between price and moving averages; we can see that: this stock is BULLISH in short-term; and NEUTRAL in mid-long term.
Bollinger Bands Analysis
Bollinger Bands has closed below upper band by 39.4%; above bottom band by 60.6%; Bollinger Bands are 74.7% wider than normal.The large width of the bands suggest high volatility as compared to PVCT's normal range. The bands have been in this wide range for 2 bars. This is often a sign that the current trend may be ending.

Stoxline

Stock Chart

Top 100 stocks

Stock News
Provectus Biopharmaceuticals, Inc. Announces Commencement Of Rights Offering ...
Tue, 31 Jan 2017 12:56:15 GMT

Provectus Biopharmaceuticals, Inc. Announces Extension of Rights Offering
Fri, 10 Feb 2017 23:37:30 GMT

0.0408
Thu, 14 Apr 2011 17:28:02 GMT

PROVECTUS ANNOUNCES PRELIMINARY RESULTS FROM PHASE 1B TRIAL OF INTRALESIONAL ...
Wed, 18 Oct 2017 13:30:00 GMT

Provectus Biopharmaceuticals, Inc. Announces Extension Of Rights Offering Due ...
Mon, 06 Mar 2017 11:02:54 GMT

Provectus Biopharmaceuticals Reestablishes Strategic Advisory Board
Thu, 20 Apr 2017 20:15:00 GMT

Trading Lines in Review for Provectus Biopharmaceuticals Inc. Warrant (PVCTW)
Thu, 19 Oct 2017 12:22:30 GMT

63% Implosion: The Epic Collapse of Provectus Biopharmaceuticals, Inc
Tue, 27 May 2014 23:03:45 GMT

Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT) Edges Forward Towards Its ...
Mon, 24 Apr 2017 15:22:30 GMT

Glancy Prongay & Murray LLP announce settlement with Provectus ...
Mon, 16 May 2016 15:31:38 GMT